艾美捷科技代理Biorelevant品牌。

Biorelevant公司成立于2006年，位于英国伦敦，是一家专注于开发和生产模拟人体胃肠道环境的体外溶出介质的公司，致力于为制药行业提供更准确、更可靠的药物溶出测试解决方案。Biorelevant公司可提供体外溶出介质：包括多种模拟人体胃肠道环境的溶出介质，用于药物溶出测试；还可以根据客户需求，提供定制化的溶出介质和测试方案并提供全面的技术支持和应用指导，帮助客户优化药物开发和测试流程。Biorelevant产品包括：FaSSIF、FeSSIF、FaSSGF、FeSSGF等多种模拟空腹和饱腹状态的溶出介质。其产品应用范围包括：

（1）药物开发，广泛应用于口服固体制剂的开发和优化，提高生物利用度和疗效；

（2）质量控制，用于药物生产过程中的质量控制，确保产品的一致性和稳定性；

（3）法规提交，支持药物注册和法规提交，提供符合监管要求的溶出测试数据。

艾美捷科技特约代理BioVendor产品。

BioVendor专注于为分子和细胞学实验室提供体外研究产品，主要产品有重组蛋白、抗体和ELISA试剂盒。目前公司致力于有关激素和细胞活素利用方面的研究，产品相关方向：能量代谢和体重调节；骨代谢；心血管疾病和肾病；感染和发炎；铁代谢研究；肌肉生长控制；神经组织损坏标记；肿瘤学；胰腺调节分子；分泌型磷脂酶A2等。

BioVendor group is an internationally operating group of companies with its own research & development and manufacturing capability. In 2012, BioVendor – Laboratorní medicína joined forces with Test Line Clinical Diagnostics followed by BioVendor Instruments, Immunolab, ViennaLab Diagnostics and Genetrac by the end of 2016. We have established a synergistic and quality-based portfolio which allows us to serve professionals from the fields of biomedical research, clinical diagnostics, veterinary diagnostics and food analysis.

BioVendor公司的主要产品包括：

Immunoassays

Proteins

Antibodies

miRNA

Planar Arrays

Immunohistochemistry

Endotoxin Detection Products

Cell-Based Assays

Extracellular Matrix Assays

Advanced Microscopes

Liquid Biopsy

Real-time PCR

Allele Biotechnology位于美国圣地亚哥市，主要专注于对生物过程的机制进行探索，以开发生物医学及治疗相关的技术和产品。以各个物种的iPS细胞、人类cGMP iPS细胞及衍生的细胞为材料，Allele Biotechnology利用专利性的非整合细胞编辑方法，开发了出了细胞治疗和药物筛选的技术。Allele Biotechnology具有深厚的基因组修饰和细胞荧光报告因子的经验，为客户提供优异的细胞检测解决方案。Allele Biotechnology还提供荧光蛋白、高效荧光素酶底物、基因分型试剂盒、骆驼抗体等产品；此外还在RNA干扰领域尤其独特的专利。

Allele Biotechnology and Pharmaceuticals, Inc. is a private, San Diego-based company that explores the mechanisms of biological processes to develop technologies and products for biomedical research and therapy development.

Our mission is to increase accessibility to innovative molecular biology research tools by offering cutting edge technologies in individual products and fully integrated platforms. Allele utilizes proprietary non-integrating cellular reprogramming methods to develop cell therapy and enable drug discovery through the use of human and non-human primate iPS cells, cGMP-grade human iPS cells and their derivatives. With additional expertise in genome modification and unique cell-based fluorescence sensors/reporters, Allele provides advanced cell and assay development solutions. Allele also has developed a wide variety of advanced research tools including superior fluorescent proteins, highly efficient luciferase assay substrates, genotyping kits, and camelid antibodies that have been validated for co-immunoprecipitation, histology, and flow cytometry. The Company has also been a leader in the RNAi field with its patents in Pol III promoter-driven siRNA, shRNA, and miRNA.